Literature DB >> 36059364

Charles Bonnet Syndrome With Superimposed Delirium.

Chelsea Karson1, Christopher Kang1, Brittany Albrecht2, Geoffrey Levin1.   

Abstract

Charles Bonnet Syndrome (CBS) is diagnosed when a patient who is psychiatrically intact experiences visual hallucinations in the setting of significant visual acuity or field loss. The exact pathophysiology of the CBS hallucinations remains largely unknown. The main theories include the deafferentation theory and perceptual release theory. There are suspected neurotransmitters involved, including acetylcholine and dopamine. There is no defined treatment protocol with medication for CBS, but various psychotropic medications have been used with varying degrees of remission of symptoms. This case report describes a 64-year-old male with Charles Bonnet Syndrome in the setting of superimposed delirium. We note the different medications that were trialed to reduce his CBS symptoms and decrease episodes of behavioral disturbances. Clinical features of this rare syndrome with superimposed delirium are summarized in hopes of providing directions for management and future study.
Copyright © 2022, Karson et al.

Entities:  

Keywords:  antipsychotic; cbs; charles bonnet syndrome; charles bonnet syndrome plus; deafferentation theory; delirium; mental health stigma; perceptual release theory; visual hallucination

Year:  2022        PMID: 36059364      PMCID: PMC9428389          DOI: 10.7759/cureus.27570

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  The neural basis of Charles Bonnet hallucinations: a hypothesis.

Authors:  W Burke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

2.  Charles Bonnet, his life, and his syndrome.

Authors:  Thomas R Hedges
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.048

3.  Evaluation of the Clinical Features, Management, and Prognoses of Patients With Charles Bonnet Syndrome.

Authors:  Huseyin Buyukgol; Faik Ilik; Devrimsel Harika Ertem
Journal:  J Nerv Ment Dis       Date:  2019-12       Impact factor: 2.254

4.  Olanzapine therapy in hallucinatory visions related to Bonnet syndrome.

Authors:  M Coletti Moja; E Milano; S Gasverde; M Gianelli; M T Giordana
Journal:  Neurol Sci       Date:  2005-07       Impact factor: 3.307

Review 5.  Charles Bonnet syndrome: are medications necessary?

Authors:  Kimberly E Hartney; Glenn Catalano; Maria C Catalano
Journal:  J Psychiatr Pract       Date:  2011-03       Impact factor: 1.325

6.  [Charles Bonnet syndrome: report of one case managed with haloperidol].

Authors:  Camila Valencia; José Gabriel Franco
Journal:  Rev Med Chil       Date:  2008-06-03       Impact factor: 0.553

7.  Family physician awareness of Charles Bonnet syndrome.

Authors:  Keith D Gordon; Tina Felfeli
Journal:  Fam Pract       Date:  2018-09-18       Impact factor: 2.267

8.  A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report.

Authors:  Sultan H Alamri
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-20       Impact factor: 2.570

9.  Hallucinations in an Elderly Patient with Severe Visual Impairment.

Authors:  Barjinder S Buttar; Alan T Kaell
Journal:  Cureus       Date:  2018-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.